Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α

Abstract Objective This research explored the involvement of MAFG-AS1 in metabolic reprogramming and potential molecular mechanisms in ovarian cancer (OC). Methods The ability of MAFG-AS1 silencing to affect the glucose intake, lactate production, ECAR, OCR and ATP concentrations and NAD+/NADH ratio...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu Jia, Fei Yu
Format: Article
Language:English
Published: Springer 2025-05-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02429-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849309718928949248
author Liu Jia
Fei Yu
author_facet Liu Jia
Fei Yu
author_sort Liu Jia
collection DOAJ
description Abstract Objective This research explored the involvement of MAFG-AS1 in metabolic reprogramming and potential molecular mechanisms in ovarian cancer (OC). Methods The ability of MAFG-AS1 silencing to affect the glucose intake, lactate production, ECAR, OCR and ATP concentrations and NAD+/NADH ratios in OC cells was examined. Cell cycle phases and apoptosis were measured by flow cytometry. The influences of MAFG-AS1overexprssion on the above assays were also identified. Results A transient reduction in the number of SKOV3 and HO8910 cells in the MAFG-AS1 knockdown group. MAFG-AS1 knockdown can inhibit cell proliferation, induce apoptosis, and enhance the number of cells in G2 phase. Silencing MAFG-AS1 can inhibit the glucose uptake rate, extracellular lactate production, and ECAR of OC cells, ATP levels, and can promote OCR and NAD+/ NADH ratio oxidative phosphorylation. Silencing MAFG-AS1 can inhibit HIF-1α in OC. Conclusion Our study revealed silencing MAFG-AS1 could inhibit the proliferation and induce apoptosis of OC cells by inhibiting the HIF-1α-mediated glycolysis process. Therefore, this study further potentially reveals the machinery of MAFG-AS1 in regulating OC cell proliferation and apoptosis, which is expected to provide a theoretical basis for the study of new targets.
format Article
id doaj-art-56a68dc07ec14ff19ac727e6b84be433
institution Kabale University
issn 2730-6011
language English
publishDate 2025-05-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-56a68dc07ec14ff19ac727e6b84be4332025-08-20T03:53:58ZengSpringerDiscover Oncology2730-60112025-05-0116111010.1007/s12672-025-02429-yOverexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1αLiu Jia0Fei Yu1Department of Pathology, The Second Affiliated Hospital, Zhejiang University School of MedicineDepartment of Pathology, The Second Affiliated Hospital, Zhejiang University School of MedicineAbstract Objective This research explored the involvement of MAFG-AS1 in metabolic reprogramming and potential molecular mechanisms in ovarian cancer (OC). Methods The ability of MAFG-AS1 silencing to affect the glucose intake, lactate production, ECAR, OCR and ATP concentrations and NAD+/NADH ratios in OC cells was examined. Cell cycle phases and apoptosis were measured by flow cytometry. The influences of MAFG-AS1overexprssion on the above assays were also identified. Results A transient reduction in the number of SKOV3 and HO8910 cells in the MAFG-AS1 knockdown group. MAFG-AS1 knockdown can inhibit cell proliferation, induce apoptosis, and enhance the number of cells in G2 phase. Silencing MAFG-AS1 can inhibit the glucose uptake rate, extracellular lactate production, and ECAR of OC cells, ATP levels, and can promote OCR and NAD+/ NADH ratio oxidative phosphorylation. Silencing MAFG-AS1 can inhibit HIF-1α in OC. Conclusion Our study revealed silencing MAFG-AS1 could inhibit the proliferation and induce apoptosis of OC cells by inhibiting the HIF-1α-mediated glycolysis process. Therefore, this study further potentially reveals the machinery of MAFG-AS1 in regulating OC cell proliferation and apoptosis, which is expected to provide a theoretical basis for the study of new targets.https://doi.org/10.1007/s12672-025-02429-yMAFG-AS1 expressionGlucose metabolism reprogrammingOvarian cancerCell proliferation/growth
spellingShingle Liu Jia
Fei Yu
Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α
Discover Oncology
MAFG-AS1 expression
Glucose metabolism reprogramming
Ovarian cancer
Cell proliferation/growth
title Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α
title_full Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α
title_fullStr Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α
title_full_unstemmed Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α
title_short Overexpression of MAFG-AS1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating HIF-1α
title_sort overexpression of mafg as1 in ovarian cancer promotes glucose metabolism reprogramming and malignant biological behavior of ovarian cancer cells by regulating hif 1α
topic MAFG-AS1 expression
Glucose metabolism reprogramming
Ovarian cancer
Cell proliferation/growth
url https://doi.org/10.1007/s12672-025-02429-y
work_keys_str_mv AT liujia overexpressionofmafgas1inovariancancerpromotesglucosemetabolismreprogrammingandmalignantbiologicalbehaviorofovariancancercellsbyregulatinghif1a
AT feiyu overexpressionofmafgas1inovariancancerpromotesglucosemetabolismreprogrammingandmalignantbiologicalbehaviorofovariancancercellsbyregulatinghif1a